Cyclerion Announces CY6463 Clinical Pipeline Progress and Second Quarter 2022 Financial Results

Go back to Cyclerion Announces CY6463 Clinical Pipeline Progress and Second Quarter 2022 Financial Results
(NASDAQ: CYCN) Delayed: 3.36 --0 (-0%)
Previous Close $3.36    52 Week High $ 
Open $3.36    52 Week Low $ 
Day High $3.36    P/E N/A 
Day Low $3.36    EPS $ 
Volume 58,415